V7

Beauty Health CoFRA Beauty Stock Report

Last reporting period 30 Sep, 2024

Updated 21 Nov, 2024

Last price

Market cap $B

0.177

Micro

Exchange

XFRA - Deutsche Boerse AG

V7A0.F Stock Analysis

V7

Uncovered

Beauty Health Co is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-3/100

Low score

Market cap $B

0.177

Dividend yield

Shares outstanding

132.5 B

The Beauty Health Co. engages in manufacturing and selling of serum-based hydradermabrasion systems and aesthetic products. The company is headquartered in Long Beach, California and currently employs 1,034 full-time employees. The company went IPO on 2020-02-10. The company and its subsidiaries designs, develops, manufactures, markets, and sells aesthetic technologies and products. Its flagship brand, HydraFacial, has created the category of hydra dermabrasion by using a patented Vortex-Fusion Delivery System (Delivery Systems) to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. The firm has omnichannel place Delivery Systems where consumers live, work, and play, including medical offices, Medi spas, day spas, hotels, resorts, gyms, wellness centers, and other retail settings. HydraFacial is accessible and appropriate for consumers across all genders, ages, and skin types. The company provides Keravive, which is a treatment designed to cleanse, exfoliate, and hydrate the scalp. HydraFacial is available in over 90 countries with an install base of approximately 20,399 Delivery Systems.

View Section: Eyestock Rating